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Structural studies on T cell receptors (TCRs) specific
for foreign antigens demonstrated a remarkably sim-
ilar topology characterized by a central, diagonal TCR
binding mode that maximizes interactions with the
MHC bound peptide. However, three recent structures
involving autoimmune TCRs demonstrated unusual
interactions with self-peptide/MHC complexes. Two
TCRs from multiple sclerosis patients bind with un-
conventional topologies, and both TCRs are shifted
toward the peptide N terminus and the MHC class II 
chain helix. A TCR from the experimental autoim-
mune encephalomyelitis (EAE) model binds in a con-
ventional orientation, but the structure is unusual be-
cause the self-peptide only partially fills the binding
site. For all three TCRs, interaction with the MHC
bound self-peptide is suboptimal, and only two or
three TCR loops contact the peptide. Optimal TCR
binding modes confer a competitive advantage for
antimicrobial T cells during an infection, whereas al-
tered binding properties may permit survival of a sub-
set of autoreactive T cells during thymic selection.
Escape from Negative Selection
by Autoreactive T Cells
Autoimmune diseases are caused by self-reactive T cells
that have escaped negative selection during T cell devel-
opment in the thymus (Goodnow et al., 2005). In many
autoimmune diseases, pathogenic T cells recognize “tis-
sue-specific” antigens, and it was previously thought that
the presence of such autoreactive T cells is due to a
lack of self-antigen expression in the thymus. However,
more recent work has convincingly demonstrated that
most tissue-specific self-antigens are in fact expressed
in the thymus by an unusual subpopulation of medul-
lary thymic epithelial cells (mTECs) that express a wide
range of tissue-specific genes in a promiscuous man-
ner (Derbinski et al., 2001). The expressed genes en-
code autoantigens relevant in human autoimmune dis-
eases; such autoantigens include myelin basic protein
(MBP) and proteolipid protein (PLP), which are consid-
ered to be target antigens in multiple sclerosis (MS)
(Pribyl et al., 1996; Derbinski et al., 2001). The promis-
cuous expression of these genes in mTECs is in part
controlled by the transcription factor AIRE, and both
humans (The Finnish-German APECED Consortium,*Correspondence: kai_wucherpfennig@dfci.harvard.edu
4 These authors contributed equally.1997) and mice with a defective AIRE gene (Anderson
et al., 2002) develop autoimmunity in multiple organs.
Several explanations for a failure of negative selec-
tion have been proposed on the basis of experiments in
animal models of autoimmunity. Particularly instructive
has been a comparison of the T cell response to a self-
antigen between wild-type and knockout mice that lack
expression of the self-antigen in question. Collectively,
these experiments have demonstrated that expression
of the self-antigen has striking effects on the T cell rep-
ertoire and that T cells directed against certain epitopes
are largely deleted, whereas T cells that recognize other
epitopes escape negative selection (Harrington et al.,
1998; Klein et al., 2000). Comparison of the CD4 T cell
response in MBP-deficient and wild-type H-2u mice
showed that the response to MBP is far more vigorous
in MBP-deficient mice and that the majority of respond-
ing T cells in MBP-deficient mice recognize the 121–
150 region of MBP (Harrington et al., 1998). In contrast,
the CD4 T cell response in wild-type H-2u mice is pri-
marily focused on the N-terminal Ac1-11 epitope of
MBP that binds with low affinity to I-Au, whereas a T cell
response to the high-affinity 121–150 peptide is barely
detectable (Zamvil et al., 1986; Harrington et al., 1998).
Alternative splicing has been implicated as another
mechanism for a failure of negative selection in another
EAE model in which the T cell response is primarily
focused on an epitope of PLP. The PLP splice variant
present in the thymus lacks the critical T cell epitope,
resulting in a selective defect of thymic negative selec-
tion to the PLP 139–151 peptide (Anderson et al., 2000;
Klein et al., 2000).
These two mechanisms—low-affinity peptide binding
and alternative splicing—do not account for the major-
ity of cases in which autoreactive T cells are present
in the mature T cell repertoire. A substantial number of
peptides that are recognized by self-reactive T cells bind
with an intermediate or high affinity to the relevant MHC
molecule (Wall et al., 1992; Valli et al., 1993; Wucherpfen-
nig et al., 1994a), and in most cases the relevant antigen
and the epitope in question are expressed in the thy-
mus (Pribyl et al., 1996; Derbinski et al., 2001). Two re-
cent studies have indicated that general alterations in
T cell signaling thresholds can profoundly affect the
outcome of thymic selection events. The molecular de-
fects can affect either early TCR signaling events or
more distal signaling pathways that initiate apoptosis
in thymocytes (Sakaguchi et al., 2003; Liston et al.,
2004). In a spontaneously occurring mouse model of
rheumatoid arthritis (SKG mice), the genetic defect was
pinpointed to the SH2 domain of ZAP-70, a tyrosine
kinase that associates with the ζ chain of the TCR-CD3
complex (Sakaguchi et al., 2003). Diminished TCR sig-
naling dramatically affected thymic selection and re-
sulted in positive selection of otherwise negatively se-
lected autoreactive T cells (Sakaguchi et al., 2003). It is
possible that alterations in TCR binding to peptide/
MHC, which modulate the strength of TCR signaling in
the thymus, can lead to a similar outcome.
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352The Conventional Topology of Peptide/MHC Class I
Binding by TCRs
The first crystal structures of TCR/peptide/MHC class I
complexes showed remarkable similarities in the over-
all topology of TCR binding to peptide/MHC, even
though the TCRs originated from two different species
and had been isolated from distinct biological settings,
a chronic infectious disease (human A6 TCR), and an
alloimmune response (murine 2C TCR) (Garboczi et al.,
1996; Garcia et al., 1996, 1998). In both structures, the
TCR is positioned diagonally across the compound sur-
face created by the peptide and the long MHC helices
that flank the peptide binding site such that the TCR
covers most of the MHC bound peptide (illustrated for
A6 TCR in Figures 1A and 1B). The most diverse TCR
loops, the CDR3 loops of TCRα and β chains, are lo-
cated over the central peptide residue and form a
pocket that accommodates this peptide side chain (P5
tyrosine of the nine amino acid Tax peptide in the A6
structure, Figures 1B–1D). This TCR position permits
extensive interactions between the most diverse TCR
loops and the central segment of the MHC bound
peptide.
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nFigure 1. The Conventional Topology of TCR
Binding to Peptide/MHC Complexes
(A and B) The conventional TCR binding
mode is illustrated with the human A6 TCR
as an example (Protein Data Bank [PDB] ac-
cession number 1AO7). This TCR recognizes
the HTLV-1 Tax 11–19 peptide bound to HLA-
A2 (Garboczi et al., 1996). The A6 TCR binds
in a diagonal orientation to the peptide/MHC
class I complex and is centered over the P5
tyrosine residue of the nine amino acid Tax
peptide. Top view from the T cell surface (A)
and side view (B) are shown; for clarity, only
the TCR variable domains, the peptide back-
bone, and the MHC helices are shown. The
side view shows the high points of the MHC
helices that are avoided by the diagonal ori-
entation of the TCR across the peptide/MHC
surface. The P5 tyrosine side chain of the
peptide is shown, and the backbone of the
peptide is colored green. The MHC helices
are colored blue (α1 helix in dark blue and
α2 helix in light blue, respectively). The Vα
and Vβ domains of TCR are colored yellow
and red, respectively. The same color code
is used throughout the figures for TCR V do-
mains, MHC molecules, and peptides.
(C) Location of the TCR loops on the pep-
tide/MHC surface. The CDR3 loops of both
TCR chains interact directly with the peptide
and form a pocket for P5 tyrosine. The
CDR1α and CDR1β loops are located over
the N-terminal and C-terminal segments of
the peptide, respectively. In the conventional
diagonal orientation, the CDR2 loops do not
contact the peptide, but make contacts to
the MHC helices. The TCRα and TCRβ chain
loops are colored yellow and red, respec-
tively. The CDR1, CDR2, and CDR3 loops are
labeled as α1, α2, and α3 for TCRα and as
β1, β2, and β3 for TCRβ.
(D) Space-filling model of the TCR variable
domains (Vα yellow, Vβ red), illustrating the TCR pocket for the P5 tyrosine side chain of the peptide located in the center of the TCR
interaction surface with peptide/MHC. The Tax peptide is shown as a stick-and-ball model. The figure was prepared with Deep View/Swiss-
PDB Viewer (Guex and Peitsch, 1997).The other TCR loops (CDR1 and CDR2) are encoded
y the V gene segments and are less diverse in se-
uence among different TCRs. The diagonal orientation
laces the CDR1 loops of TCRα and TCRβ over the
-terminal and C-terminal segments of MHC class I
ound peptides (Figure 1C), such that a total of four
CR loops (CDR1 and CDR3 loops of both chains) can
articipate in peptide recognition. The CDR1 loops can
lso contact the MHC helices. In contrast, the CDR2
oops of both chains are positioned over the MHC heli-
es and do not participate in peptide recognition in
hese structures (Figure 1C) (Garcia et al., 1999; Hen-
ecke and Wiley, 2001; Rudolph and Wilson, 2002).
The TCR surface that contacts peptide/MHC was
ound to be rather flat, with the exception of the central
avity described above. In contrast, the MHC helices
orm two high points at opposite ends, and the TCR
voids these high points by a diagonal orientation (Fig-
re 1B). Subsequent MHC class I/peptide/TCR struc-
ures enforced the view that this binding topology may
e general and led to the hypothesis that the germline-
ncoded CDR1 and CDR2 loops have evolved to recog-
ize structural features of MHC molecules (Ding et al.,
Review
3531998; Garcia et al., 1999; Reiser et al., 2000, 2002, 2003;
Hennecke and Wiley, 2001; Rudolph and Wilson, 2002;
Stewart-Jones et al., 2003). A contribution of the CDR1
or CDR2 loop of TCRα to MHC binding was shown by
experiments in which single amino acid substitutions in
these TCR loops affected T cell differentiation to the
CD4 or CD8 lineage (Sim et al., 1996). However, muta-
genesis experiments failed to identify conserved MHC
side chains required for recognition by all TCRs (Sun et
al., 1995; Baker et al., 2001).
MHC Class II Restricted TCRs that Recognize
Foreign Peptides Also Bind
with Conventional Topology
Subsequently, the structures of two MHC class II re-
stricted TCRs were determined that recognize foreign
peptides: the mouse D10 TCR specific for a conalbu-
min peptide bound to I-Ak (Reinherz et al., 1999), and
the human HA1.7 TCR specific for an influenza hemag-
glutinin (HA, residues 306–318) peptide bound to HLA-
DR1 (DRA, DRB1*0101) (Figure 2A; Table 1) (HenneckeFigure 2. Altered Topology of Self-Peptide/MHC Binding by Two Human Autoimmune TCRs
(A) The HA1.7 TCR (PDB accession number 1FYT) is specific for the influenza HA 306–318 peptide bound to DRA, DRB1*0101 and binds with
a conventional topology over the center of the peptide/MHC surface. The white sphere marks the position of the P5 peptide residue in the
center of the binding site over which the CDR3 loops of the TCRα and β chains converge.
(B) The 3A6 TCR was isolated from a patient with MS and recognizes the MBP 89–101 peptide bound to DRA, DRB5*0101 (PDB accession
number 1ZGL). Compared to HA1.7 TCR, the position of this TCR is shifted toward the peptide N terminus and the DRβ chain helix (the lower
helix in all three DR molecules in this figure).
(C) The Ob.1A12 TCR was isolated from another MS patient and recognizes a different epitope of MBP (residues 85–99) bound to another
HLA-DR molecule (DRA, DRB1*1501) (PDB accession number 1YMM). This TCR is also shifted toward the peptide N terminus and tilted
toward the DRβ chain helix. In addition, it is rotated counterclockwise relative to HA1.7 TCR. This counterclockwise rotation distinguishes it
from 3A6 TCR. The TCR Vα and Vβ domains are colored in yellow and red, respectively, the MHC molecule in blue, and the bound peptide in
green. The figure was prepared with Molscript (http://www.avatar.se/molscript/) and rendered with Raster3d (Merritt and Murphy, 1994).Table 1. MHC Class II Restricted TCRs for which the Structure of TCR/Peptide/MHC Complex Has Been Determined
TCR Peptide MHC Class II Species
TCRs Specific for Foreign Peptides
HA1.7 Influenza hemagglutinin, 306–318 DRA, DRB1*0101 Human
D10 Conalbumin, 131–144 I-Ak Mouse
TCRs Specific for Self Peptides
Ob.1A12 Human myelin basic protein, 85–99 DRA, DRB1*1501 Human
3A6 Human myelin basic protein, 89–101 DRA, DRB5*0101 Human
172.10 Mouse myelin basic protein, Ac1–11 I-Au Mouse
The HA1.7 and D10 TCRs are specific for foreign peptides, whereas the human Ob.1A12 and 3A6 TCRs as well as the murine 172.10 TCR
recognize different epitopes of the self-antigen myelin basic protein.
The overall similarities between these initial structureset al., 2000). In contrast to MHC class I molecules, the
peptide binding site of MHC class II molecules is open
at both ends, permitting binding of longer peptides
(Brown et al., 1993). Despite these differences between
MHC class I and class II molecules, both of these MHC
class II restricted TCRs bind with a very similar topol-
ogy as the MHC class I restricted TCRs described
above. The only substantial difference between MHC
class I and class II restricted TCRs appeared to be the
crossing angle (defined by a line drawn through the pep-
tide and a line through the centers of mass of the TCR
variable domains) because the first structure of an MHC
class II restricted TCR (D10 TCR) (Reinherz et al., 1999)
suggested a more orthogonal position (80°) than pre-
viously reported structures for MHC class I restricted T
cells (45°–70°) (Garcia et al., 1999). However, subse-
quent studies demonstrated that there are no global
differences in the binding angle between MHC class I
and class II restricted TCRs (Hennecke and Wiley, 2001;
Rudolph and Wilson, 2002; Stewart-Jones et al., 2003).
Immunity
354of MHC class I and class II TCR complexes further en-
forced the notion that all TCRs bind to peptide/MHC
complexes in a similar fashion. All human TCRs ana-
lyzed in these studies recognized viral peptides, and
the T cell clones from which they had been isolated
represented predominant T cell populations in the im-
mune response to the virus. In vivo competition (Kedl
et al., 2003) may therefore have resulted in the expan-
sion of T cells whose TCRs have optimal binding prop-
erties for these viral peptide/MHC ligands.
Unconventional Topology of Self-Peptide/MHC
Binding by a TCR from a Multiple Sclerosis Patient
The first crystal structure of a human autoimmune TCR
(Ob.1A12 TCR) bound to its self-peptide/MHC ligand
showed a strikingly different topology (Figure 2C) (Hahn
et al., 2005), which was surprising given the strong sim-
ilarities between all of the previously reported TCR/
peptide/MHC structures. The Ob.1A12 TCR originated
from a patient with relapsing-remitting MS and is spe-
cific for a major epitope of human MBP (residues 85–
99) bound to a MS-associated MHC class II molecule
(DRA, DRB1*1501) (Ota et al., 1990; Wucherpfennig et
al., 1994a). Transgenic mice that express this human
TCR and the MHC class II molecule develop a sponta-
neous inflammatory disease in the CNS that has sim-
ilarities with the human disease, demonstrating that
this TCR has the potential to be pathogenic in vivo
(Madsen et al., 1999; Ellmerich et al., 2004). The struc-
ture showed that the Ob.1A12 TCR is not centered over
the peptide/MHC surface and that it only contacts the
N-terminal segment of the peptide (Figure 2C). In addi-
tion, the TCR does not make symmetrical interactions
with the MHC helices, but is shifted and tilted toward
the DRβ chain helix. Another unusual feature is the
counterclockwise rotation of Ob.1A12 TCR relative to
the MHC molecule when compared to HA1.7 TCR. The
crossing angle is 70° for HA1.7 TCR, within the 45°–80°
range observed for other TCRs, but 110° for Ob.1A12
TCR. This altered position of the TCR dramatically af-
fects peptide recognition. This is particularly evident in
the position of the two CDR3 loops, which create a
large cavity over the P2 side chain, rather than the P5
side chain (Figures 3C, 4, and 5C, left panel). The lateral
shift in the location of the CDR3 loops is substantial
and corresponds to three peptide residues. The cavity
created by the CDR3 loops not only accommodates a
peptide side chain (P2 histidine, Figure 3C), but also a
side chain from a MHC helix (DRβ81 histidine, Figure
5C, left panel).
Several other rules thought to be universally applica-
ble to TCR recognition do not apply to this TCR. The
majority of contacts to the MHC helices are made by
the hypervariable CDR3 loops rather than by the germ-
line-encoded CDR1 and CDR2 loops (Figure 5C). Par-
ticularly prominent is the contribution of the TCRβ
CDR3 loop, which spans across the peptide binding
site and contacts both MHC helices (Figure 5C, left
panel). The majority of residues in this TCR loop that
contact the MHC helices (three out of four residues) are
encoded by randomly inserted N-region nucleotides at
the V-D-J junction, indicating that the unique sequence
elements of this TCR make a significant contribution to
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Pigure 3. Unusual Location of the TCR CDR3α and CDR3β Loops
ver the MHC Bound Peptide in the 3A6 and Ob.1A12 Structures
A) The influenza HA peptide is shown as a stick model with the
eptide backbone and side chain carbons in gray and the nitrogen
nd oxygen atoms in blue and red, respectively. The two CDR3
oops meet over the P5 side chain of the HA peptide. Only the
ackbone of the CDR3 loops (yellow, CDR3α; red, CDR3β) is shown
o avoid crowding.
B and C) In the 3A6 (B) and Ob.1A12 (C) structures, the CDR3
oops are instead positioned over the P2 peptide residue, a lysine
n the 3A6 structure, and a histidine in the Ob.1A12 structure. The
DR3β loop of Ob.1A12 TCR forms lateral contacts with the P5
ysine of the MBP peptide. The figure was prepared with Deep
iew/Swiss-PDB Viewer (Guex and Peitsch, 1997) and POV-Ray
http://www.povray.org/).HC binding. It therefore appears that unconventional
opologies are possible because of the sequence diver-
ity of TCRs in the CDR3 loops.
The functional relevance of the topology observed in
his structure is supported by a large body of experi-
ental data. Experiments with peptide analogs had
emonstrated that P2 histidine and P3 phenylalanine
epresent important TCR contact residues (Wucher-
fennig et al., 1994a; Hausmann et al., 1999), and the
tructure shows that the CDR3 loops are centered over
2 histidine (Figure 3C) and make a number of interac-
Review
355Figure 4. Peptide Contacts Established by
TCR CDR3 Loops in Human and Murine
TCR/Peptide/MHC Class II Structures
The peptide residues that occupy the P1, P4,
P6, and P9 pockets of the MHC class II pep-
tide binding site are colored light blue in all
five peptide sequences. Peptide residues
contacted by CDR3 loops are colored or-
ange, and contacts to CDR3α or CDR3β are
indicated by shaded areas. Contacts that
represent hydrogen bonds are marked with
a dotted line, which is colored red when the
contact involves a side chain of the peptide.
In the HA1.7 (human) and D10 (mouse) struc-
tures in which the TCR recognizes a foreign
peptide, both CDR3 loops are located over
the center of the peptide. In contrast, both
human autoimmune TCRs (Ob.1A12 and
3A6) are characterized by a shift of the CDR3
loops toward the N terminus of the peptide.
The mouse 172.10 TCR recognizes the N-ter-
minal MBP Ac1-11 peptide that only partially
fills the peptide binding site. This structure
also contains a peptide extension by the in-
sect leader peptide, which is not part of the
native MBP peptide and thus not included in
this figure. The CDR3 loops of D10 TCR do
not form hydrogen bonds to the peptide, but
a hydrogen bond is present between the
CDR1α loop and P2 arginine of the peptide.tions with both P2 histidine and P3 phenylalanine (Fig-
ure 4). The structure also explains why any substitution
in the C-terminal segment of the peptide that is not
contacted by the TCR in this structure had no effect on
TCR recognition as long as it did not reduce MHC bind-
ing (Wucherpfennig et al., 1994a; Hausmann et al., 1999).
Furthermore, it accounts for the observation that an
N-terminal extension of the peptide up to the P −4 resi-
due was required for optimal T cell stimulation (Wuch-
erpfennig et al., 1994a). In the structure, the backbone
of the P −4 residue is contacted by the TCRβ CDR2
loop, which is located in a very unusual position in this
complex (Figure 5C, right panel).
These results raised the question of whether this TCR
represents an isolated case (Wilson and Stanfield,
2005). The T cell response to MBP in this MS patient
was largely focused on this epitope because 60 of 75
T cell lines reactive with MBP responded to the MBP
(84–102) peptide (Wucherpfennig et al., 1994b). A sec-
ond independent T cell clone (Ob.2F3) from this patient
had the same Vα-Jα and Vβ-Jβ rearrangements, and
the TCR protein sequences differed only at one position
in CDR3α and two positions in CDR3β to Ob.1A12 TCR
(Wucherpfennig et al., 1994b). This T cell clone had a
remarkably similar fine specificity to Ob.1A12 when as-
sayed on a large panel of peptide analogs. The only
difference among these clones was observed with ana-
logs of P5 lysine (Hausmann et al., 1999), a peptide side
chain that is contacted in the Ob.1A12 structure by a
CDR3β residue that differs between the two TCRs (Fig-ure 3C). The Ob.1A12 and Ob.2F3 TCRs therefore make
very similar interactions with the MBP peptide, strongly
suggesting that the overall topology is almost identical.
The Structure of a Second Human Autoreactive TCR
Also Shows an Unconventional Topology
The recent structure of a second TCR from a different
MS patient (3A6 TCR) provides another example of an
unusual interaction of an autoimmune TCR with a self-
peptide/MHC complex (Figure 2B) (Li et al., 2005). This
TCR also recognizes MBP (residues 89–101), but the
peptide is shifted by three residues in the HLA-DR bind-
ing site such that a different set of peptide residues is
available for TCR recognition (Figure 4). As a conse-
quence, peptide residues VxHFxK are solvent exposed
in the P −1 to P5 segment in the Ob.1A12 complex,
compared to FxKNxV in the 3A6 complex. In addition,
two different MHC class II molecules are involved:
DRB1*1501 (Ob.1A12) and DRB5*0101 (3A6), both of
which are associated with susceptibility to MS (Hillert,
1994). Previous studies had shown that this MBP pep-
tide binds in different registers to these MHC molecules
(Vogt et al., 1994; Wucherpfennig et al., 1994a). Thus,
both the MHC and the peptide epitope differ between
these trimolecular complexes.
Compared to TCRs with conventional topology such
as HA1.7 (Figure 2A), the position of the 3A6 TCR (Fig-
ure 2B) is shifted toward the N terminus of the peptide
and the DRβ chain helix (the lower helix in all MHC
structures in Figure 2). This shift is thus a common fea-
Immunity
356Figure 5. Location of the TCR Loops on the
Peptide/MHC Surface in the Three Human
TCR/Peptide/MHC Class II Structures
In the left panel, the CDR3 loops are located
over the center of the peptide/MHC surface
in the HA1.7 structure, but are shifted toward
the peptide N terminus in the 3A6 and
Ob.1A12 structures. The CDR3α (yellow) and
CDR3β (red) loops are labeled as α3 and β3,
respectively. Residues involved in hydrogen
bonds are represented as small spheres.
In the right panel, the CDR1 and CDR2 loops
of TCRβ chains are located in different posi-
tions in each of the three structures, and
their position is most extreme in the Ob.1A12
structure. The position of the CDR1 and
CDR2 loops of TCRα chains is more similar
among the three structures, but the CDR2α
loop of 3A6 TCR fails to contact peptide/
MHC. The CDR1 and CDR2 loops of TCRα
and β are labeled as α1, α2, β1, and β2. The
figure was prepared with Deep View/Swiss-
PDB Viewer (Guex and Peitsch, 1997) and
POV-Ray (http://www2.povray.org/).ture between 3A6 and Ob.1A12 TCRs (Figure 2B and
2C, respectively), and it substantially alters recognition
of both peptide and MHC. Whereas the CDR3 loops of
HA1.7 TCR meet over the central peptide residue P5
(Figure 3A, CDR3α colored yellow and CDR3β colored
red), the CDR3 loops of both 3A6 and Ob.1A12 TCRs
create a pocket that accommodates the P2 side chain
of the respective peptide (Figure 3B and 3C, respec-
tively). For both 3A6 and Ob.1A12 TCRs, the P2 peptide
side chain is critical for recognition because substitu-
tion of P2 lysine (3A6 TCR) or P2 histidine (Ob.1A12
TCR) by any other residue abrogates T cell activation
(Hausmann et al., 1999; Hemmer et al., 2000). The shift
toward the peptide N terminus is also evident on a map
of the peptide residues contacted by the CDR3α and
CDR3β loops (Figure 4, peptide residues contacted by
CDR3 loops colored orange). Whereas the CDR3 loops
of HA1.7 TCR establish contacts with the peptide over
the central peptide segment spanning from P −1 to P8,
the footprint of the CDR3 loops of Ob.1A12 and 3A6
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5CRs is located over the N-terminal peptide segment,
panning from P −2 to P5 for Ob.1A12 TCR and P −3
o P3 for 3A6 TCR. The binding angle of 3A6 TCR is 47°
nd thus falls within the range observed for the majority
f TCRs (45°–80°) (Rudolph and Wilson, 2002). The two
uman autoimmune TCRs thus differ substantially in
he crossing angle (47° for 3A6 TCR and 110° for
b.1A12 TCR) even though they share a shift toward
he N terminus of the peptide. Both human TCRs that
ecognize self-peptide/MHC complexes therefore have
nusual binding properties that distinguish them from
CRs specific for peptides from infectious agents.
ubstantial Differences in Both Peptide and MHC
inding by Three Human MHC Class II
estricted TCRs
omparison of the three human MHC class II restricted
CRs (HA1.7, 3A6 and Ob.1A12) demonstrates large
ifferences in the location of several TCR loops (Figure
). In these three structures, the CDR3 loops of TCRα
Review
357(colored yellow) and TCRβ (colored red) assume a dif-
ferent conformation and position: They are centered
over the P5 peptide position in the HA1.7 structure but
located over the P2 peptide residue in the 3A6 and
Ob.1A12 structures (Figure 5, left panels). Also, the
CDR3 loops of Ob.1A12 TCR make a larger number of
contacts to the MHC helices than the CDR1 and CDR2
loops. Particularly unusual is the interaction between
the CDR3α loop of Ob.1A12 TCR and a histidine resi-
due of the MHC class II molecule (DRβ81 histidine, Fig-
ure 5C, left panel); this histidine residue is located in
the central cavity between the two CDR3 loops in the
Ob.1A12 structure.
Large differences are also observed in the position
of the germline-encoded CDR1 and CDR2 loops of the
TCRβ chain in these three structures (Figure 5, right
panels). These loops are located in an entirely different
position in the Ob.1A12 structure compared to the
HA1.7 structure, and the CDR2β loop of Ob.1A12 TCR
establishes a highly unusual interaction with the N-ter-
minal residue of the MBP peptide (Figure 5C, right
panel). The unusual location of these TCRβ chain loops
is in part caused by a 40° counterclockwise rotation of
the variable domains of Ob.1A12 TCR relative to HA1.7
TCR. Significant differences in the location of the CDR1
and CDR2 loops of TCRβ are also observed between
the HA1.7 and 3A6 structures (Figures 5A and 5B, right
panels). In the 3A6 structure, the CDR2β loop is posi-
tioned directly over the DRα helix, and the CDR1β loop
is located closer to the peptide (Figures 5A and 5B,
right panels) because of the shift of the TCR toward the
peptide N terminus and the DRβ chain helix (the lower
MHC helix in all pictures in Figure 5).
Nevertheless, the CDR1 and CDR2 loops of TCRα are
in a similar overall location in all three structures (Figure
5, right panels). In the 3A6 structure, the CDR2α loop
does not contact the MHC molecule (Figure 5B, right
panel), and only a limited number of MHC contact resi-
dues are shared between the CDR1α loops of these
TCRs (contacts to DRβ 77 by all three TCRs, contacts
to DRβ 81 by 3A6 and HA1.7 TCRs, and contacts to
DRβ 76 by 3A6 and Ob.1A12 TCRs). None of the con-
tacts made by the CDR1α loops of these TCRs to the
MHC molecule represent hydrogen bonds. The sim-
ilarity in the location of the CDR1 and CDR2 loops of
TCRα is the only feature that the Ob.1A12 TCR has in
common with TCRs that bind with a conventional topol-
ogy to peptide/MHC.
Structural Characteristics of a TCR that Causes EAE
The structure of the TCR/peptide/MHC complex has
also been recently determined for the TCR from a T cell
clone that causes EAE (172.10 TCR) (Maynard et al.,
2005). This clone recognizes the acetylated N-terminal
peptide of MBP (Ac1-11) bound to the mouse MHC
class II molecule I-Au (Zamvil et al., 1986; Goverman et
al., 1993). As discussed in the introduction, this MBP
peptide binds with low affinity to I-Au and is immuno-
dominant in wild-type, but not MBP-deficient, mice (Fair-
child et al., 1993; Harrington et al., 1998). TCR binding to
this peptide is unusual because the peptide only par-
tially fills the MHC class II binding site, as shown in
Figure 4 where the peptides are aligned on the basis oftheir MHC anchor residues (He et al., 2002). 172.10 TCR
only establishes a limited number of contacts to the
MBP-peptide segment that occupies part of the bind-
ing site, and only two TCR loops are involved in con-
tacts to the MBP peptide (CDR3α and CDR3β) (Figure
4), compared to four TCR loops in the HA1.7 structure
(CDR1 and CDR3 loops of both chains) (Figure 4; Figure
5A, left and right panels). As a consequence, 172.10
TCR recognizes a substantially shorter span of the pep-
tide (six MBP peptide residues from P3 to P8, Figure 4)
compared to HA1.7 and D10 TCRs (nine HA peptide
residues, from P −1 to P8). These results, combined
with the low affinity of Ac1-11 to I-Au (Fairchild et al.,
1993), provide an explanation for the finding that an-
other region of MBP (the 121–150 segment) is immuno-
dominant in MBP-deficient mice and that T cell reactiv-
ity to Ac1-11 only becomes prominent when T cells that
recognize the 121–150 region are deleted in the thymus
(Harrington et al., 1998). The interaction with the MHC
bound peptide is thus highly unusual in the 172.10
structure, even though this TCR binds in a conventional
diagonal orientation to the Ac1-11/I-Au complex. In the
Ob.1A12 TCR structure, the interaction surface with
the peptide is also reduced by the altered position of
the TCR on the peptide/MHC surface, and again only
two TCR loops contact peptide side chains. All three
autoimmune TCRs for which the structure has been de-
termined thus differ substantially in the interaction with
peptide/MHC compared to TCRs specific for foreign
antigens.
Distinct Selection Pressures Exerted on Self-Reactive
and Antimicrobial T Cells
Foreign antigens are normally not present during T cell
development in the thymus, and as a result, T cells that
express TCRs with an optimal fit for a given microbial
peptide/MHC complex are not deleted from the reper-
toire. During an infection, there is intense competition
among T cells that recognize peptides derived from the
infectious agent, leading to the outgrowth of those clones
that express TCRs with the highest affinity for the most
abundant peptide/MHC complexes (Busch and Pamer,
1999; Kedl et al., 2000). When the TCR repertoire against
a peptide from an infectious agent is analyzed, this
clonal competition is reflected by the predominance of
clones with particular TCR rearrangements. The HA1.7
TCR is a representative of such a predominant T cell
population because its Vβ segment is highly overrepre-
sented among HA 306–318-specific T cells. The Vβ seg-
ments commonly used by HA 306–318-specific T cells
share acidic residues in the CDR1 loop that form a salt
bridge to the P8 lysine of the HA peptide in the HA1.7
structure (Wedderburn et al., 1995; Hennecke et al.,
2000). The central diagonal position of the HA1.7 and
D10 TCRs that recognize foreign peptides bound to
MHC class II molecules appears to represent the opti-
mal binding mode that maximizes the interaction sur-
face with the bound peptide.
Autoreactive T cells face different selection pres-
sures. Comparison of the T cell repertoire between
mice that lack expression of a particular autoantigen
and wild-type mice has shown that a substantial num-
ber of T cells are deleted in the thymus in the presence
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358of the autoantigen and that T cells with certain peptide
specificities are more severely affected (Harrington et
al., 1998; Klein et al., 2000). The structures of the three
autoimmune TCRs that have been determined reveal in
each case unusual TCR binding properties that appear
to result in suboptimal recognition of the MHC bound
self-peptide. For the two human TCRs, it results from
an altered TCR position over the peptide/MHC surface,
whereas for the murine TCR, it is the consequence of
partial filling of the peptide binding site by the N-ter-
minal MBP Ac1-11 peptide. It is likely that T cells with
an optimal conventional binding mode to a self-peptide/
MHC complex are present in animals rendered deficient
in expression of the self-antigen, but when the autoanti-
gen is present, such T cells may be more susceptible
to negative selection than T cells with altered binding
properties.
Low-Affinity TCR Binding and Crossreactivity
Binding studies have demonstrated low-affinity interac-
tions of both Ob.1A12 and 3A6 TCRs with their peptide/
MHC ligands. In Biacore experiments, binding could
only be detected when either the TCR or the peptide/
MHC was made multivalent (Appel et al., 2000; Li et al.,
2005). The affinity of the two human MBP-reactive TCRs
thus appears to be substantially lower than for other
crystallized TCRs for which such measurements have
been made (Li et al., 2005). The affinity of TCR interac-
tion with peptide/MHC is critical in setting the thresh-
olds for positive and negative selection in the thymus;
low-affinity ligands have been shown to promote posi-
tive selection, whereas higher-affinity ligands induce
negative selection (Alam et al., 1996). The HA1.7 TCR
binds with higher avidity to its peptide/MHC ligand than
Ob.1A12 TCR because the HA1.7 T cell clone is brightly
labeled by dimeric or multimeric peptide/MHC (Coch-
ran et al., 2000) whereas the Ob.1A12 T cell clone is
only weakly stained (Appel et al., 2000). However, the
affinity of HA1.7 binding to DR1/HA peptide has not
been measured by Biacore. The 172.10 TCR has been
reported to have an affinity within the normal range of
interactions between TCR and peptide/MHC, but it has
to be kept in mind that these experiments used a re-
combinant peptide/MHC ligand in which the low-affinity
interaction of the MBP peptide with the MHC molecule
was stabilized by covalent attachment to the MHC β
chain (Garcia et al., 2001; Maynard et al., 2005).
For both human TCRs, peptide recognition appears
to be suboptimal: In the case of Ob.1A12 TCR, only two
TCR loops contact peptide side chains, whereas four
HA1.7 TCR loops are involved in direct recognition of
the viral peptide. In the case of 3A6 TCR, no hydrogen
bonds or salt bridges are observed between TCR loops
and the MHC bound peptide. The shift toward the pep-
tide N terminus may constitute an important compo-
nent of suboptimal peptide recognition for both TCRs.
Overall, the autoimmune TCRs establish a limited num-
ber of contacts to the peptide, and only a small number
of these contacts represent hydrogen bonds (Figure 4).
Particularly striking is the observation that only two
TCR loops contact the MHC bound peptide in both the
murine 172.10 and the human Ob.1A12 structures.
It is possible that autoreactive T cells that express
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such TCRs are inherently more peptide crossreactive
ecause microbial peptides that create a better inter-
ace with these TCRs can represent ligands that are
ore potent. Such crossreactivity may be relevant for
he activation of autoreactive T cells by microbial pep-
ides during infections (Fujinami and Oldstone, 1985;
ucherpfennig and Strominger, 1995; Hemmer et al.,
997). Analogs of the relevant self-peptides have been
dentified that significantly improve T cell stimulation,
ith the most striking example being a substitution at
−1 from phenylalanine to tryptophan that augmented
he stimulatory capacity of the peptide for the 3A6 T
ell clone by several orders of magnitude, presumably
y increasing the affinity of TCR interaction with pep-
ide/MHC (Hemmer et al., 2000). The 172.10 TCR ap-
ears to be less crossreactive than the two human
BP-reactive TCRs because sequence identity with
he self-peptide is required at three peptide positions
Maynard et al., 2005), but a substantial number of mi-
robial peptides that are recognized by this TCR have
evertheless been identified (Grogan et al., 1999).
ontribution of TCR/MHC Coevolution and Thymic
election to TCR Topology
t has been suggested that the conventional topology
epresents the product of coevolution of TCR and MHC
enes (Garcia and Adams, 2005). The new structures
emonstrate that alternative binding modes are pos-
ible, indicating that coevolution may not be the only
xplanation for the predominant conventional topology.
t is possible that unconventional binding topologies
re fairly common in the TCR repertoire before positive
nd negative selection have occurred and that one of
he functions of thymic selection is to eliminate T cells
hose TCRs bind to peptide/MHC with a geometry out-
ide of the functionally useful range.
A common feature of TCR binding to both MHC class
and class II molecules is the general location of the
DR1 and CDR2 loops of TCRα (Figure 5, right panels),
ut it is not known whether essential contacts are made
o the corresponding MHC helix or whether a particular
eometry is required, for example for coreceptor func-
ion. A substantial effort has been made to identify
HC residues essential for TCR binding (Baker et al.,
001), but these experiments have failed to identify uni-
ersal MHC contact residues. The new structures dem-
nstrate that most of the TCR loops can bind to pep-
ide/MHC in alternative locations. Nevertheless, certain
HC residues are contacted by TCRs in several struc-
ures and may thus be significant for a substantial sub-
et of receptors. For example, three of the five MHC
lass II restricted TCRs for which the structure is known
HA1.7, D10, 172.10) form a salt bridge between glu-
amic acid 56 in the CDR2 loop of TCRβ and lysine 39
n the MHC class II α chain (DRα39 in the HA1.7 com-
lex, Figure 5A, right panel). This contact is not made
y the Ob.1A12 and 3A6 TCRs because of the altered
opology of TCR binding to peptide/MHC.
The structures of the two human autoimmune TCRs
ave shown that not all αβ TCRs bind with the same
verall topology to peptide/MHC complexes. At pres-
nt, it is not known whether the Ob.1A12 TCR repre-
ents the most extreme case of an alternative topology
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359and what range of alternative topologies are compati-
ble with TCR function. It is even possible that a single
TCR can bind with different topologies to distinct pep-
tide/MHC complexes and that alternative topologies
are thus extreme cases of TCR crossreactivity.
An interesting question is whether a shift, observed
for both Ob.1A12 and 3A6 TCRs, toward the peptide N
terminus and the MHC class II β chain helix is a com-
mon alternative topology, a finding that would suggest
that this arrangement alters the assembly of higher-
order signaling complexes in a way that is favorable for
autoreactive T cells, for example during thymic selec-
tion. Alterations in the biochemical interaction between
TCR and peptide/MHC may modify TCR signaling
thresholds during thymic selection, analogous to the
changes in TCR signaling thresholds described in the
SKG model of spontaneous arthritis, in which a point
mutation in ZAP-70 leads to positive selection of auto-
reactive T cells that are otherwise negatively selected
(Sakaguchi et al., 2003). Additional structures, in par-
ticular of TCRs from other autoimmune diseases, are
needed to determine what fraction of autoreactive
TCRs have unusual binding properties. Such an effort
will require a global analysis of TCR binding properties
in terms of affinity, overall topology, and interaction sur-
face with peptide. The three available structures show
that each autoimmune TCR has individual features that
distinguish it from antimicrobial TCRs. Escape from
negative selection may for individual TCRs be due to a
distinct combination of structural and functional alter-
ations, such as reduced affinity, suboptimal interface
with peptide, and altered topology.
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